Edition:
United States

Integra LifeSciences Holdings Corp (IART.OQ)

IART.OQ on NASDAQ Stock Exchange Global Select Market

47.56USD
17 Nov 2017
Change (% chg)

$0.08 (+0.17%)
Prev Close
$47.48
Open
$47.28
Day's High
$47.70
Day's Low
$46.98
Volume
120,628
Avg. Vol
207,567
52-wk High
$56.39
52-wk Low
$37.71

Chart for

About

Integra LifeSciences Holdings Corporation is a medical technology company. The Company focuses on the development, manufacturing, and marketing of surgical implants and medical instruments. Its segments include Specialty Surgical Solutions, which offers specialty surgical instrumentation for a range of specialties, including... (more)

Overall

Beta: 0.64
Market Cap(Mil.): $3,732.39
Shares Outstanding(Mil.): 78.48
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 51.22 15.79
EPS (TTM): -- -- --
ROI: -- 13.48 12.01
ROE: -- 20.00 15.91

BRIEF-Integra Lifesciences Q3 adjusted earnings per share $0.45

* Integra Lifesciences reports third quarter 2017 financial results

Oct 26 2017

BRIEF-JNJ announces completion of Codman Neurosurgery divestiture to Integra Lifesciences

* Johnson & Johnson announces completion of Codman Neurosurgery divestiture to Integra Lifesciences Holding Corporation Source text for Eikon: Further company coverage:

Oct 02 2017

FTC approves Integra purchase of J&J’s Codman business

WASHINGTON Medical device maker Integra LifeSciences Holdings Corp has received U.S. antitrust approval to buy Johnson & Johnson's Codman Neuro Division, the Federal Trade Commission said on Wednesday.

Sep 27 2017

U.S. FTC approves Integra purchase of J&J’s Codman business

WASHINGTON Medical device maker Integra LifeSciences Holdings Corp has received U.S. antitrust approval to buy Johnson & Johnson's Codman Neuro Division, the Federal Trade Commission said on Wednesday.

Sep 27 2017

UPDATE 1-U.S. FTC approves Integra purchase of J&J’s Codman business

WASHINGTON, Sept 27 Medical device maker Integra LifeSciences Holdings Corp has received U.S. antitrust approval to buy Johnson & Johnson's Codman Neuro Division, the Federal Trade Commission said on Wednesday.

Sep 27 2017

FTC allows Integra to buy J&J’s Codman neuro business, with conditions

WASHINGTON, Sept 27 Medical device maker Integra LifeSciences Holdings Corp has received U.S. antitrust approval to buy Johnson & Johnson's Codman Neuro Division, the Federal Trade Commission said on Wednesday.

Sep 27 2017

BRIEF-Integra lifesciences reports preliminary assessment of damage to Puerto Rico facility

* Integra Lifesciences provides preliminary assessment of minor damage to its manufacturing facility in Añasco, Puerto Rico

Sep 26 2017

BRIEF-Integra LifeSciences announces first patient enrolled in Cadence® total ankle system post-market study

* Integra LifeSciences announces first patient enrolled in Cadence® total ankle system post-market study Source text for Eikon: Further company coverage:

Sep 21 2017

BRIEF-Natus to acquire neurosurgery assets from Integra Lifesciences

* Natus to acquire neurosurgery assets from Integra Lifesciences, enters neurosurgery market

Sep 11 2017

BRIEF-Integra Lifesciences to sell neurosurgery assets to Natus Medical

* Integra Lifesciences announces definitive agreement to sell certain neurosurgery assets to Natus Medical Incorporated

Sep 11 2017

Earnings vs. Estimates